Core Scientific Inc [CORZ] stock is trading at $11.80, up 7.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CORZ shares have gain 4.61% over the last week, with a monthly amount glided 35.01%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Core Scientific Inc [NASDAQ: CORZ] stock has seen the most recent analyst activity on May 22, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $15. Previously, Keefe Bruyette started tracking the stock with Outperform rating on January 27, 2025, and set its price target to $22. On January 21, 2025, Craig Hallum initiated with a Buy rating and assigned a price target of $24 on the stock. ROTH MKM started tracking the stock assigning a Buy rating and suggested a price target of $25.50 on November 15, 2024. Jefferies initiated its recommendation with a Buy and recommended $19 as its price target on October 28, 2024. Macquarie started tracking with a Outperform rating for this stock on September 25, 2024, and assigned it a price target of $16. In a note dated September 23, 2024, Canaccord Genuity initiated an Buy rating and provided a target price of $16 on this stock.
Core Scientific Inc [CORZ] stock has fluctuated between $4.74 and $18.63 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. Core Scientific Inc [NASDAQ: CORZ] shares were valued at $11.80 at the most recent close of the market. An investor can expect a potential return of 86.44% based on the average CORZ price forecast.
Analyzing the CORZ fundamentals
Core Scientific Inc [NASDAQ:CORZ] reported sales of 410.91M for the trailing twelve months, which represents a drop of -55.64%. Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -2.3%, and Net Profit Margin reading is -2.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.58, Equity is 1.34 and Total Capital is -0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-6.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.23 points at the first support level, and at 10.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.11, and for the 2nd resistance point, it is at 12.43.
Ratios To Look Out For
For context, Core Scientific Inc’s Current Ratio is 4.26. As well, the Quick Ratio is 4.26, while the Cash Ratio is 3.57. Considering the valuation of this stock, the price to sales ratio is 8.55.
Transactions by insiders
Recent insider trading involved TODD DUCHENE, Officer, that happened on Jun 03 ’25 when 60000.0 shares were purchased. Director, Rozov Yadin completed a deal on May 28 ’25 to buy 0.11 million shares. Meanwhile, DUCHENE TODD M sold 50000.0 shares on May 27 ’25.
